AVLN

Latest SEC Filings & News for AVLN

2 most recent filings and news items mentioning AVLN. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/AVLN/news?limit=20"

Pull AVLN filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 17, 2026Positive

Avalyn Pharma completes enrollment of 375 patients in Phase 2b MIST trial

Avalyn Pharma announced completion of target enrollment in its Phase 2b MIST clinical trial evaluating AP01 (inhaled pirfenidone) for progressive pulmonary fibrosis, with topline results expected in H2 2027. The milestone demonstrates strong investigator and patient demand for ne

View filing at SEC.gov →

OfferingJun 3, 2026Positive

Avalyn Pharma reports Q1 2026 results, IPO raises $345M for pipeline advancement

Avalyn completed an upsized IPO raising $345 million gross proceeds and reported progress on three pulmonary fibrosis programs, with MIST Phase 2b enrollment on track for mid-2026 completion. The company has sufficient capital to fund operations into 2029, with clinical readouts

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.